Dr. Turtle is currently the senior vice president of portfolio management and corporate development at BridgeBio. Prior to joining the company, he was a consultant in McKinsey & Company’s Silicon Valley office, where he worked with biotech, pharmaceutical and medical product companies on strategy for mergers and acquisitions, due diligence, growth and clinical trial strategy, and commercial operations. He is an author of multiple peer-reviewed publications in cardiology and biomechanics. Dr. Turtle earned his DPhil in cardiovascular medicine as a Rhodes Scholar at the University of Oxford, and his BS in bioengineering from the University of Washington.